期刊文献+

小剂量红霉素治疗生物膜形成相关的慢性绿脓杆菌肺部感染的临床研究 被引量:1

Effects of low-dose erythromycin treating the biofilm form associated chronic pulmonary infection originated from pseudomonas aeruginosa
暂未订购
导出
摘要 目的评价长期应用小剂量红霉素治疗生物膜形成相关的慢性绿脓杆菌肺部感染的临床疗效。方法选择40例稳定期慢性阻塞性肺疾病(COPD)合并慢性绿脓杆菌肺部感染患者,随机分为治疗组和对照组,每组20例,其中治疗组是在基础治疗的基础上加用口服红霉素125mg,3次/天;对照组仅用基础治疗。基础治疗包括:吸氧,允许使用稳定剂量的茶碱、口服或吸入支气管扩张剂,但不允许使用其它大环内酯类药和激素。两组疗程均为3个月。结果3个月治疗结束后观察痰细菌清除率情况:治疗组细菌清除率60%(12/20),对照组20%(4/20),两组相比差异显著(P<0.05)。治疗组肺功能(FEV1):治疗前(0.69±0.13)L,治疗后(0.83±0.18)L;生活质量评分情况:治疗前47.6±5.13,治疗后33.8±4.89,较对照组有明显改善(P均<0.05)。结论长期应用小剂量红霉素可抑制和破坏绿脓杆菌形成的生物膜,有利于绿脓杆菌的清除,并能改善稳定期COPD合并慢性绿脓杆菌肺部感染患者的肺功能和生活质量。 Objective To evaluate the clinical efficacy of low-dose long-term erythromycin treating the biofilm form associated chronic pulmonary infection originated from pseudomonas aeruginosa. Methods A prospective double-blind controlled trial randomized 40 patients with stable COPD with chronic pulmonary infection colonized by pseudomonas aeruginosa to trial group (20 patients) or control group (20 patients). The basic treatments included oxygen therapy, therapy with theocin in safe dose, therapy with inhaled or oral bronchodilators were involved in both groups, 3 months' therapy with oral erythromycin 125mg three times daily in the trial group; only basic treatments were involved in the control group, time of therapy was also 3 monthes. Corticosteroid could not be involved in either group. Bacterial clearance of sputum, FEV1, improvements in symptom scores were determined at the end of therapy. Results The bacterial clearance of sputum was 60% (12/20) in the trial group and 20% (4/20) in the control group. There was statistically significant between two groups(P〈0.05). The average FEV 1 of trial group was (0.69~0.13 ) L before treatment with erythromycin, (0.83~0.18) L after treatment; Improvements in symptom scores was 47.6~5.13 before treatment, 33.8~4.89 after treatment with erythromycin in the trial group, had significant improvement than the control group. Conclusion Therapy with low-dose long-term Erythromycin can inhibit and destroy the biofilm of pseudomonas aeruginosa, be benefit to the pathogen eradication, and improve the pulmonary function and quality of life.
出处 《中国现代医药杂志》 2006年第10期1-3,共3页 Modern Medicine Journal of China
基金 广西南宁市科技局科技基金资助项目(No.20020340C)
关键词 红霉素 绿脓杆菌 生物膜 慢性阻塞性肺疾病 Erythromycin Pseudomonas aeruginosa Biofilm COPD
  • 相关文献

参考文献4

  • 1[1]Parnham MJ.Immunomodulatory effects of antimicrobials in the therapy of respiratory tract infections.Curr Op in Infect Dis,2005,18:125-131
  • 2孔晋亮,莫诚航,尚为民,邝敏,覃雪军,闫萍,陈一强.红霉素、左氧氟沙星对铜绿假单胞菌生物被膜作用的体外研究[J].广西医科大学学报,2005,22(3):347-350. 被引量:7
  • 3[4]Macleod CM,Hamid QA,Cameron L,et al.Anti-inflammatory activity of clarithromycin in adults with chronically inflamed sinus mucosa.Adv Ther,2001,18(2):75-82
  • 4[5]Amsden GW.Anti-inflammatory effects of macrolides-an under appreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother,2005,55(1):10-21

二级参考文献11

  • 1Rashid MH, Rumbaugh K, Passador L, et al. Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of pseudomonas aeruginosa. Proc Natl Acad Sci USA,2000,97(17):9 636-9 641.
  • 2Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms., a common cause of persistent infections. Science, 1999,21,284(5 418):1318-1322.
  • 3Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. The Lancet, 2001,358(9 276): 135-138.
  • 4Ishida H, Ishida Y, Kurosaka Y, et al. In vitro and in vivo activities of levofloxacin against biofilm-producing pseudomonas aeruginosa. Antimicrob Agents Chemother,1998,42(7):1641-1645.
  • 5Nickel JC, Heaton J, Morales A, et al. Bacterial biofilm in persistent penile prosthesis-associated infection. J Urol, 1986,135(3): 586-588.
  • 6Passariello C, Berlutti F, Selan L, et al. A rapid staining procedure to demonstrate glycocalyx production and bacterial biofilms. Microbiologica, 1994,17 (3): 225-230.
  • 7Bui KQ, Banevicius MA, Nightingale CH, et al. In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid pseudomonas aeruginosa. J Antimicrob Chemother, 2000,45 ( 1 ), 57-62.
  • 8Scottile FD, Marrie TJ, Prough DS,et al. Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes. Crit Care Med, 1986,14(4):265.
  • 9Tanaka G, Shigeta M, Komatuzawa H, et al. Effect of the growth rate of pseudomonas aeruginosa biofilm on the susceptility to antimicrobial agents: beta-lactams and fluoroquinolones. Chemotherapy, 1999,45 ( 1 ) : 28-36.
  • 10Shigeta M, Tanka G, Komatuzawa H, et al. Permeation of antimicrobial agents through pseudomonas aeruginosa biofilms : a simple method. Chemotherapy, 1997,43 ( 5 ) :340-345.

共引文献6

同被引文献23

  • 1魏广兴.克拉霉素联合加替沙星治疗慢性阻塞性肺疾病急性发作期铜绿假单胞菌感染[J].实用医学杂志,2005,21(7):735-736. 被引量:6
  • 2Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol, 2007, 10(6): 644-648.
  • 3Lasa I. Towards the identification of the common features of bacterial biofilm development. IntMicrobiol, 2006, 9(1): 21-28.
  • 4Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev, 2002, 15(2): 167-193.
  • 5Szewzyk U, Szewzyk R, Manz W, et al. Microbiological safety of drinking water. Annu Rev Microbiol, 2000, 54:81-127.
  • 6McMath SM, Holt DM. The fate of Escherichia coli through water treatment and in distribution. Syrup Ser Soc Appl Microbiol, 2000, (29): 117S-123S.
  • 7Rodrнguez A, Autio WR, McLandsborough LA. Effect of biofilm dryness on the transfer of Listeria monocytogenes biofilms grown on stainless steel to bologna and hard salami. J Food Prot, 2007, 70(11): 2480-2484.
  • 8Howell D, Behrends B. A review of surface roughness in antifouling coatings illustrating the importance of cutoff length. Biofouling, 2006, 22(5-6): 401-410.
  • 9Davies D. Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov, 2003, 2(2): 114-122.
  • 10Lewis K. Persister cells and the riddle ofbiofilm survival. Biochemistry (Mosc), 2005, 70(2): 267-274.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部